Search Results 61-70 of 37877 for Two-phase
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. This is a Phase 1b/2, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of B-701 plus docetaxel versus ...
This phase 1b trial is an open-label study designed ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.
This trial consists of two phases: 16 weeks of double-blind treatment and 24 weeks of open-label extension. Participation eligibility. Participant ...
The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as ...
This study will be conducted in two phases. In phase 1 subjects will be randomized into 3 cohorts in a 28-day cycles. Phase 2, 80 new subjects will be ...
A Phase II study to investigate the potential utility of PD 0332991 in the treatment of early stage ER+ Human epidermal growth factor receptor 2 (HER2)- breast ...
This is a single-arm, two-stage, phase II trial to assess the efficacy of futibatinib plus pembrolizumab in advanced hepatocellular carcinoma for patients with ...
... Phase 2 dose (RP2D) and schedule of KTX-1001 for ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.